| Citation: |
CHENG Hai-bo, WANG Jun-yi. Discussion on Biological Basis of Cancer Toxin Pathogenesis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(3): 241-244.
|
| [1] |
程海波， 沈卫星， 吴勉华， 等. 基于肿瘤微环境的癌毒病机理论研究[J]. 南京中医药大学学报， 2014，30(2):105-107.
|
| [2] |
程海波， 王俊壹， 李柳. 癌毒病机分类及其在肿瘤临床治疗中的应用[J]. 中医杂志， 2019，60(2):119-122.
|
| [3] |
LOGOZZI M， CAPASSO C， DI RAIMO R， et al. Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity[J]. J Enzyme Inhib Med Chem， 2019，34(1):272-278.
|
| [4] |
KING HW， MICHAEL MZ， GLEADLE JM. Hypoxic enhancement of exosome release by breast cancer cells[J]. BMC Cancer， 2012，12:421.
|
| [5] |
郑舞， 杨金坤. 肿瘤微环境及其中医病机[J]. 中医杂志， 2015，56(20):1720-1724.
|
| [6] |
陆文秀. 晚期胃肠道肿瘤血瘀程度与外周血肿瘤缺氧相关蛋白关系[J]. 中国实验方剂学杂志， 2013，19(23):301-306.
|
| [7] |
程海波， 吴勉华. 周仲瑛教授“癌毒”学术思想探析[J]. 中华中医药杂志， 2010，25(6):866-869.
|
| [8] |
RUIVO CF， ADEM B， SILVA M， et al. The biology of cancer exosomes: Insights and new perspectives[J]. Cancer Res， 2017，77(23):6480-6488.
|
| [9] |
CAMUSSI G， DEREGIBUS MC， TETTA C. Tumor-derived microvesicles and the cancer microenvironment[J]. Curr Mol Med， 2013，13(1):58-67.
|
| [10] |
程海波. 癌毒病机理论探讨[J]. 中医杂志， 2014，55(20):1711-1715.
|
| [11] |
WANG Z， CHEN JQ， LIU JL， et al. Exosomes in tumor microenvironment: novel transporters and biomarkers[J]. J Transl Med， 2016，14(1):297.
|
| [12] |
WELTON JL， KHANNA S， GILES PJ， et al. Proteomics analysis of bladder cancer exosomes[J]. Mol Cell Proteomics， 2010，9(6):1324-1338.
|
| [13] |
AL-NEDAWI K， MEEHAN B， MICALLEF J， et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells[J]. Nat Cell Biol， 2008，10(5):619-624.
|
| [14] |
CORCORAN C， RANI S， O'BRIEN K， et al. Docetaxel-resistance in prostate cancer: Evaluating associated phenotypic changes and potential for resistance transfer via exosomes[J]. PLoS ONE， 2012，7(12):e50999.
|
| [15] |
MARTINS VR， DIAS MS， HAINAUT P. Tumor-cell-derived microvesicles as carriers of molecular information in cancer[J]. Curr Opin Oncol， 2013，25(1):66-75.
|
| [16] |
CARISSIMI C， CARUCCI N， COLOMBO T， et al. miR-21 is a negative modulator of T-cell activation[J]. Biochimie， 2014，107:319-326.
|
| [17] |
DUNAND-SAUTHIER I， SANTIAGO-RABER ML， CAPPONI L， et al. Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function[J]. Blood， 2011，117(17):4490-4500.
|
| [18] |
CURTALE G， CITARELLA F， CARISSIMI C， et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes[J]. Blood， 2010，115(2):265-273.
|
| [19] |
LI W， KONG L B， LI J T， et al. MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5[J]. Int Immunol， 2014，26(5):269-281.
|
| [20] |
LIU C， YU S， ZINN K， et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function[J]. J Immunol， 2006，176(3):1375-1385.
|
| [21] |
周仲瑛， 程海波， 周学平， 等. 中医药辨治肿瘤若干理念问题的探讨[J]. 南京中医药大学学报， 2014，30(2):101-104.
|
| [22] |
ZHAO H， YANG L， BADDOUR J， et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism[J]. Elife， 2016，5:e10250.
|
| [23] |
SKOG J， WURDINGER T， VAN RIJN S， et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers[J]. Nat Cell Biol， 2008，10(12):1470-1476.
|
| [24] |
TADOKORO H， UMEZU T， OHYASHIKI K， et al. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells[J]. J Biol Chem， 2013，288(48):34343-34351.
|
| [25] |
SUBRA C， GRAND D， LAULAGNIER K， et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins[J]. J Lipid Res， 2010，51(8):2105-2120.
|
| [26] |
ATRETKHANY KN， DRUTSKAYA MS， NEDOSPASOV SA， et al. Chemokines， cytokines and exosomes help tumors to shape inflammatory microenvironment[J]. Pharmacol Ther， 2016，168:98-112.
|
| [27] |
WHITESIDE T L. Exosomes in cancer: Another mechanism of tumor-induced immune suppression[J]. Adv Exp Med Biol， 2017，1036:81-89.
|
| [28] |
YIN Y， CAI X， CHEN X， et al. Tumor-secreted miR-214 induces regulatory T cells: A major link between immune evasion and tumor growth[J]. Cell Research， 2014，24(10):1164-1180.
|
| [29] |
LOBB R J， LIMA L G， MOLLER A. Exosomes: Key mediators of metastasis and pre-metastatic niche formation[J]. Semin Cell Dev Biol， 2017，67:3-10.
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: